A Phase Ib Trial Of Fulvestrant+Cdk4/6 Inhibitor (Cdk4/6i) Palbociclib Plus Pan-Fgfr Tyrosine Kinase Inhibitor (Tki) Erdafitinib In Fgfr-Amplified/Er+/Her2-Negative Metastatic Breast Cancer (Mbc)
CANCER RESEARCH（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要